Treatment options for polycystic ovary syndrome

Figures & data

Table 1 Diagnostic criteria

Organization/group	Year	Criteria
National Institutes of Health	1990	Both hyperandrogenism and chronic anovulation^Citation5
Rotterdam European Society for Human Reproduction/American Society of Reproductive Medicine-sponsored PCOS consensus workshop group	2003	Two of the following conditions: hyperandrogenism, chronic anovulation, polycystic ovary^Citation6
Androgen Excess Society	2006	Hyperandrogenism and ovarian dysfunction (including infrequent or irregular ovulation or anovulation) and/or polycystic ovary^Citation7

Abbreviation: PCOS, polycystic ovary syndrome.

DunaifAInsulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesisEndocr Rev19971867748009408743

 PubMed Web of Science ®Google Scholar

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertil Steril20048111925

 Web of Science ®Google Scholar

AzzizRCarminaEDewaillyDPosition statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guidelineJ Clin Endocrinol Metab200691114237424516940456

 PubMed Web of Science ®Google Scholar